FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Janssen's supplemental application for CONCERTA (methylphenidate hydrochloride), updating labeling per the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)